跳至主要内容
临床试验/ISRCTN96130697
ISRCTN96130697已完成不适用

Clinical evaluation of Hemocontrol in hypotension-prone hemodialysis patients: a multicenter prospective cross-over study

Gambro Korea Ltd. (Korea, South)0 个研究点目标入组 71 人开始时间: 2011年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
71

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Hypotension-prone patients, i.e. patients showing symptomatic hypotensive episodes in response to fluid removal by dialysis in 25% or more of treatments during 1 month preceding the study
  • 2. Mostly showing an inter-dialytic weight gain of 1.5 kg or more
  • 3. Age between 18 and 75 years
  • 4. On dialysis for at least 3 months, on three dialysis per week schedule

排除标准

  • 1. A regular pre-dialysis mean arterial blood pressure in supine position of <90 mmHg
  • 2. Regular blood flow rate for dialysis lower than 200 ml/min
  • 3. Ppre-dialysis hemoglobin level regularly above 13 g/dl
  • 4. Treatment by hemodiafiltration (HDF)
  • 5. Expected need for blood transfusions

研究者

发起方
Gambro Korea Ltd. (Korea, South)

相似试验